A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells
about
Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients.PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
P2860
A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A benzimidazole derivative exh ...... tes DR5 in breast cancer cells
@ast
A benzimidazole derivative exh ...... tes DR5 in breast cancer cells
@en
type
label
A benzimidazole derivative exh ...... tes DR5 in breast cancer cells
@ast
A benzimidazole derivative exh ...... tes DR5 in breast cancer cells
@en
prefLabel
A benzimidazole derivative exh ...... tes DR5 in breast cancer cells
@ast
A benzimidazole derivative exh ...... tes DR5 in breast cancer cells
@en
P2093
P2860
P356
P1476
A benzimidazole derivative exh ...... tes DR5 in breast cancer cells
@en
P2093
P2860
P356
10.1038/CDDIS.2015.25
P577
2015-03-12T00:00:00Z